Pirfenidone effectively reverses experimental liver fibrosis

This publication has 21 references indexed in Scilit:

• Liver Cirrhosis Is Reverted by Urokinase-Type Plasminogen Activator Gene Therapy
  Molecular Therapy, 2000
• Cholestasis-induced fibrosis is reduced by interferon α-2a and is associated with elevated liver metalloprotease activity
  Journal of Hepatology, 2000
• Mechanisms and Therapy of Hepatic Fibrosis: Report of the Aasld Single Topic Basic Research Conference
  Hepatology, 2000
• Intramuscular Injection of an Adenoviral Vector Expressing Hepatocyte Growth Factor Facilitates Hepatic Transduction with a Retroviral Vector in Mice
  Human Gene Therapy, 1999
• Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
  Kidney International, 1998
• Pirfenidone: A Novel Pharmacological Agent That Inhibits Leiomyoma Cell Proliferation and Collagen Production
  Journal of Clinical Endocrinology & Metabolism, 1998
• The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
  New England Journal of Medicine, 1993
• Kupffer cells from carbon tetrachloride-injured rat livers produce chemotactic factors for fibroblasts and monocytes: The role of tumor necrosis factor-α
  Hepatology, 1991
• Carbon tetrachloride hepatotoxicity:status quo and future prospects
  Trends in Pharmacological Sciences, 1983
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976